Long-term recombinant human growth hormone therapy in Dent’s disease type 1
Not required for Clinical Vignette.
Miao Huang +5 more
doaj +1 more source
Dent’s disease: case series from a single center
Background. Dent’s disease (DD) is a rare X-linked recessive tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis and chronic kidney disease.
Hilal Yaşar +5 more
doaj +1 more source
A sibling with Dent disease without mutations of OCRL1 and CLCN5
Kimata, Takahisa +5 more
openaire +2 more sources
Genetic Screening of Patients With Inherited Fanconi Syndrome. [PDF]
Inoki Y +24 more
europepmc +1 more source
CLCN5 inhibits tumorigenesis and fatty acid accumulation in clear cell renal cell carcinoma by regulating Enoyl CoA hydratase and 3-Hydroxyacyl CoA dehydrogenase. [PDF]
Yu T +6 more
europepmc +1 more source
Molecular Basis of Rare Inherited Tubulopathies of the Kidney: A Primer for Clinicians. [PDF]
Vecino-Pérez M +4 more
europepmc +1 more source
Dual-Genetic Etiology in an Atypical Dent Disease Phenotype Which Combines Features of Focal Segmental Glomerulosclerosis and Ellis-Van Creveld-Like Syndrome: A Case Report. [PDF]
Del Prete D +8 more
europepmc +1 more source
Genetic background of infantile hypophosphatemia: a narrative review. [PDF]
Zeng X, Hu L.
europepmc +1 more source
Phenotype and genotype analyses of 21 Chinese patients with Dent disease. [PDF]
Che R, Cai Y, Zhou W, Zhao S, Huang S.
europepmc +1 more source
Bioinformatics analysis of a <i>CLCN5</i> geneframeshift mutation in a patient with Dent disease. [PDF]
Zhang Y, Li N, Fan L, Liu J.
europepmc +1 more source

